Prediction of Bioactive Compounds Using Computed NMR Chemical Shifts

Combinatorial Chemistry and High Throughput Screening

Volumn 18, Issue 6, 2015, Pages 562-576

  Karthikeyan, Muthukumarasamy ^a   Rajamohanan, Pattuparambil Ramanpillai ^a   Vyas, Renu ^a  

^a NATIONAL CHEMICAL LABORATORY   (India)

Author keywords

Chemical shift; Fingerprints; NMR; Similarity searching; Virtual screening

Indexed keywords

ANTIANDROGEN; ANTICONVULSIVE AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; ANTIPSORIASIS AGENT; ANTIVIRUS AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CORTICOSTEROID; GESTAGEN; PROTON; STEROID; ACETYLSALICYLIC ACID; ANTIDIABETIC AGENT; MOLECULAR LIBRARY;

ANALYTIC METHOD; ARTICLE; BIOLOGICAL ACTIVITY; CARBON NUCLEAR MAGNETIC RESONANCE; CHEMICAL ANALYSIS; CHEMICAL STRUCTURE; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; COMBINATORIAL LIBRARY; DRUG SCREENING; FINGER DERMATOGLYPHICS; MEASUREMENT ACCURACY; MOLECULAR BIOLOGY; PHARMACOPHORE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SENSITIVITY ANALYSIS; STRUCTURE ANALYSIS; CHEMISTRY; DRUG DEVELOPMENT; INFORMATION PROCESSING; MOLECULAR LIBRARY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

ASPIRIN; DATASETS AS TOPIC; DRUG DISCOVERY; HYPOGLYCEMIC AGENTS; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR STRUCTURE; SMALL MOLECULE LIBRARIES;

EID: 84942100049     PISSN: 13862073     EISSN: 18755402     Source Type: Journal    
DOI: 10.2174/1386207318666150703113312     Document Type: Article

References (48)

1. Sotriffer A.; Huang, D.; Caflisch, A. Fragment-based approaches in virtual screening. Methods Princ. Med. Chem. 48, Chapter In: Virtual Screening principles, challenges and practical guidelines. 2011, Wiley, 467-489.
2. Badrinarayan, P.; Sastry, G. N. Virtual screening filters for the design of type II p38 MAP kinase inhibitors: A fragment based library generation approach. J. Mol. Graphics Model., 2012, 34, 89-100.
3. Hoffer, L.; Renaud, J.-P.; Horvath, D. Fragment-based drug design: computational and experimental state of the art. Comb. Chem. High Throughput Screen., 2011, 14 (6), 500-520.
4. Dalvit, C.; Fasolini, M.; Flocco, M.; Knapp, S.; Pevarello, P.; Veronesi, M. NMR-Based screening with competition water-ligand observed via gradient spectroscopy experiments: detection of highaffinity ligands. J. Med. Chem., 2002, 45(12), 2610-2614.
5. Shuker, S.B.; Hajduk, P.J.; Meadows, R.P.; Fesik, S.W. Discovering high affinity ligands for proteins SAR by NMR. Science, 1996, 274(5292), 1531-1534.
6. Venkitakrishnan, R. P.; Benard, O.; Max, M.; Markley, J. L.; Assadi-Porter, F. M. Use of NMR saturation transfer difference spectroscopy to study ligand binding to membrane proteins. Methods Mol Biol., In: Membrane Protein Structure and Dynamics. 2012, Humana Press, 47-63.
7. Wagstaff, J. L.; Taylor, S. L.; Howard, M. J. Recent developments and applications of saturation transfer difference nuclear magnetic resonance (STD NMR) spectroscopy. Mol. BioSyst., 2013, 9(4), 571-577.
8. Dalvit, C.; Ardini, E.; Fogliatto, G. P.; Mongelli, N.; Veronesi, M. Reliable high-throughput functional screening with 3-FABS. Drug Discov. Today, 2004, 9(14), 595-602.
9. Vogtherr, M.; Fiebig, K. NMR based screening methods for lead discovery. EXS, 2003, 93, 183-202.
10. Hajduk, P. J.; Burns, D. J. Integration of NMR and high-throughput screening. Comb. Chem. High Throughput Screen., 2002, 5(8), 613-621.
11. Spanton, S.G.; Whittern, D. The development of an NMR chemical shift prediction application with the accuracy necessary to grade proton NMR spectra for identity. Magnetic Resonance in Chemistry, 2009, 47(12), 1055-1061.
12. Walker, G. S.; O'Connell, T. N. Comparison of LC-NMR and conventional NMR for structure elucidation in drug metabolism studies. Expert Opin. Drug Metab. Toxicol., 2008, 4(10), 1295- 1305.
13. Schultz, J. Practical aspects of using nmr in fragment based screening. In: Fragment based drug discovery A practical approach, Shapiro, M.J., Zartler, R., Eds. Wiley and Sons Ltd.: UK, 2008.
14. Hahn, S.; Achenbach, J.; Buscato, E.; Klingler, F.-M.; Schroeder, M.; Meirer, K.; Hieke, M.; Heering, J.; Barbosa-Sicard, E.; Loehr, F.; Fleming, I.; Doetsch, V.; Schubert-Zsilavecz, M.; Steinhilber, D.; Proschak, E. Complementary Screening Techniques Yielded Fragments that Inhibit the Phosphatase Activity of Soluble Epoxide Hydrolase. Chem. Med. Chem., 2011, 6 (12), 2146-2149.
15. Fernandez, C.; Wolfgang, J. New Approaches for screening in drug discovery. Drug Discov. Today, 2004, 1, 277-283.
16. Callaghan, P. T. Principles of nuclear magnetic resonance microscopy. Oxford: Clarendon Press, 1991, 3, 41-48.
17. Wishart, D.S.; Sykes, B.D.; Richards, F.M. The chemical shift index: A fast and simple method for the assignment of protein secondary structure through spectroscopy. Biochemistry, 1992, 31(6), 1647-1651.
18. Saito, H; Ando, I.; Ramamoorthy, A. Chemical shift tensor -the heart of NMR: Insights into biological aspects of proteins. Prog. Nucl. Magn. Reson. Spectrosc., 2010, 57(12), 181-228.
19. Gupta R.R.; Lechner, M.D. Eds. Chemical shift and coupling constants for hydrogen-1. Springer: Vol. 35 C1, 2000.
20. Egolf, D.S.; Brockett, E.B.; Jurs, P.C. Simulation of carbon 13 nuclear magnetic resonance spectra of methyl substituted nor bornane-2-ols. Anal Chem., 1988, 60, 2700-2706.
21. Kooistra, A. J.; Binsl, T. W.; van Beek, J. H.; de Graaf, C.; Heringa, J. Electron density fingerprints (EDprints): virtual screening using assembled information of electron density. J. Chem. Inf. Model., 2010, 50(10), 1772-1780.
22. Abad-Zapatero, C. Ligand efficiency indices for effective drug discovery. Expert Opin. Drug Discov., 2007, 2(4), 469-488.
23. Willett, P. Similarity searching using 2D structural fingerprints. Methods Mol. Biol., 2011, 671, 133-158.
24. M. Karthikeyan, Vyas Renu, Rajmohanan, P.R. Development of NMR chemical shift fingerprints and applications. WO 2014/207670 A1.
25. Rees, D.C.; Congreve, M.; Murray, C.W.; Carr, R. Fragment based lead discovery. Nat. Rev. Drug Discov., 2004, 3, 660-672.
26. http://www.nmrdb.org/(Accessed on 2 February 2015).
27. Huang, N.; Shoichet, B.K.; Irwin, J.J. Benchmarking sets for molecular docking. J. Med. Chem., 2006, 49(23), 6789-6801.
28. http://www.cambridgesoft.com/Ensemble-for-Chemistry/ChemDraw/(Accessed on 2 February 2015).
29. https://www.chemaxon.com/marvin/help/calculations/.html (Accessed on 2 February 2015).
30. http://mestrelab.com/software/mnova/nmr/(Accessed on 2 February 2015).
31. http://www.wavefun.com/(Accessed on 2 February 2015).
32. https://rapidminer.com/(Accessed on 2 February 2015).
33. http://bonsai.hgc.jp/mdehoon/software/cluster/software.htm (Accessed on 2 February 2015).
34. jtreeview.sourceforge.net/(Accessed on 2 February 2015).
35. http://www.chemcomp.com/MOEMolecular-Operating-Environment.htm (Accessed on 2 February 2015).
36. Abraham, R.; Mobli, M. A Practical Approach to 1H NMR calculation and prediction. In: Modelling 1H NMR Spectra of Organic Compounds: Theory, Applications and NMR Prediction Software. Eds: Wiley & Sons. 2008, 349-368.
37. Claridge, T. Software Review of MNova: NMR Data Processing, Analysis, and Prediction Software. J. Chem. Inf. Model., 2009, 49(4), 1136-1137.
38. http://www.gaussian.com/(Accessed on 2 February 2015).
39. http://www.schrodinger.com/Jaguar/(Accessed on 2 February 2015).
40. http://www.chm.bris.ac.uk/pt/harvey/elstruct/hf-method.html (Accessed on 1 February 2015).
41. Jain, R.; Bally, T.; Rablen, P. R. Calculating accurate proton chemical shifts of organic molecules with density functional methods and modest basis sets. J. Org.Chem., 2009, 74(11), 4017- 4023.
42. Head-Gordon, M.; Pople, J. A.; Frisch, M. J. MP2 energy evaluation by direct methods. Chem. Phys. Lett., 1988, 153(6), 503- 506.
43. Karthikeyan, M.; Pandit, D.; Vyas, R. Chemscreener: A Distributed computing tool for scaffold based Virtual Screening Tool for Lead Discovery. Comb. Chem. High Throughput Screen., 2015.
44. Karthikeyan, M.; Vyas, R.; Tambe, S.S.; Radhamohanan, D.; Kulkarni, B.D. Comb. Chem. High Throughput Screen., 2015.
45. Douglass, J. G. et al. Lipophilic modifications to dinucleoside polyphosphates and nucleotides that confer antagonist properties at the platelet P2Y12 receptor. J. Med. Chem., 2008, 51(4), 1007-1025.
46. Muller, C. E.; Jacobson, K. A. Xanthines as adenosine receptor antagonists. In: Methylxanthines, Eds: Springer Berlin Heidelberg, 2011, 151-199.
47. Kirk, D. N.; Marples, B. A. The structure and nomenclature of steroids. In Steroid Analysis, Eds: Springer Netherlands, 1995, 1-24.
48. Seal, A.; Yogeeswari, P.; Sriram, D.; Wild, D. J. OSDD Consortium. Enhanced ranking of PknB Inhibitors using data fusion methods. J. Cheminform., 2013, 5(1), 1-11.